Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in sun pharmaceuticals

Sun Pharma Forays Into Nutrition Bar Segment With Launch Of Revital NXT

The market for nutrition bars in India is growing rapidly, with an increasing focus on fitness for a healthy lifestyle.

Read More

Sun Pharma Shares Zoom 10 %; M-Cap Jumps Rs 16,970.94 Cr After Earnings

Consolidated revenue from operations stood at Rs 9,718.74 crore for the quarter under consideration. It was Rs 7,585.25 crore for the same period a year ago

Read More

No Plans To Get Into Vaccine Production As It Requires Separate Manufacturing Infra: Sun Pharma

The Mumbai-based company, which is strong in various generic therapeutic segments, is eyeing biosimilars to fuel its future growth.

Read More

Sun Pharma Acquires Rights To Trademarks Of 3 Diabetes Drug Brands In India From AstraZeneca

AstraZeneca India and Sun Pharma have discontinued their existing distribution services agreement signed in 2016, for distribution of Dapagliflozin.

Read More

Sun Pharma Q4 Net Profit Zooms Over Two-Fold To Rs 894.15 Cr

Shares of Sun Pharmaceutical Industries closed at Rs 699.75 per scrip on BSE, down 0.55 per cent from its previous close.

Read More

Sun Pharma Recalls 50,868 Bottles Of Diabetes Drug In US

The US-based arm of the drug firm is recalling the affected lot of 500 mg tablets (in 500 count bottles) due to 'presence of foreign substance identified as activated carbon', as per the latest Enforcement Report issued by the US health regulator.

Read More

Sun Pharma Appoints Pawan Goenka, Rama Bijapurkar As Additional Independent Directors

Bijapurkar has an independent management consulting practice, works across sectors, and describes her domain as bringing market focus to business strategy.

Read More

Sun Pharma, Alembic Recall Products In The US Market

Princeton (New Jersey) based Sun Pharmaceutical Industries Inc is also recalling 2,520 bottles of diabetes drug, Metformin HCl Extended-Release tablets, in the US market.

Read More

Sun Pharma To Launch Complete Range Of Generic Anti-Epilepsy Drug

Brivaracetam belongs to the class of anti-epileptic drugs (AEDs) which have a unique or different mechanism of action compared to the existing treatment options. It has fast onset of action and promising efficacy.

Read More

Sun Pharma, Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI

Sebi had received two whistleblower complaints, wherein allegations were made against Sun Pharmaceutical Industries Ltd (SPIL) and its wholly-owned subsidiary Sun Pharmaceutical Laboratories Ltd (SPLL), alleging that the firms had been diverting funds through its sole distributor in India, Aditya Medisales Ltd.

Read More

Equity Indices End Flat After Choppy Trade, Energy Stocks Lose

BSE S&P Sensex was down by 46 points or 0.13 per cent at 34,916 while the Nifty 50 edged lower by 10 points or 0.1 per cent at 10,302.

Read More

Sun Pharma Testing Plant-based Drug As Potential COVID-19 Treatment

The company said the trial will be conducted across 12 centers in India in 210 patients and a human safety study of the drug has been completed.

Read More

Sun Pharma Initiates Phase Two Clinical Trial On AQCH As Potential Treatment For COVID-19 Patients

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and India's top pharmaceutical company.

Read More

Sun Pharma To Conduct Clinical Trial Of Pancreatitis Drug In COVID-19 Patients

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.

Read More

Sun Pharma's Board Aprroves Share Buyback Worth Rs 1,700 Cr

Shares of Sun Pharmaceutical Industries were trading at Rs 380.70 per scrip on BSE, up 3.23 per cent from its previous close.

Read More